6-hydroxydopamine-induced p38 activation in rat nigral dopaminergic neurons is reduced by treatment with a novel phospholipid-based drug formulation

Typeset version

 

TY  - CONF
  - S Crotty, P Fitzgerald, DM Harris, A Fisher, A Mandel, AE Bolton, AM Sullivan, Y Nolan.
  - FENS Forum of Neuroscience, Vienna, Austria.
  - 6-hydroxydopamine-induced p38 activation in rat nigral dopaminergic neurons is reduced by treatment with a novel phospholipid-based drug formulation
  - 2006
  - January
  - Validated
  - 1
  - ()
DA  - 2006/01
ER  - 
@inproceedings{V19908169,
   = {S Crotty,  P Fitzgerald and  DM Harris,  A Fisher and  A Mandel,  AE Bolton and  AM Sullivan,  Y Nolan. },
   = {FENS Forum of Neuroscience, Vienna, Austria.},
   = {{6-hydroxydopamine-induced p38 activation in rat nigral dopaminergic neurons is reduced by treatment with a novel phospholipid-based drug formulation}},
   = {2006},
   = {January},
   = {Validated},
   = {1},
   = {()},
  source = {IRIS}
}
AUTHORSS Crotty, P Fitzgerald, DM Harris, A Fisher, A Mandel, AE Bolton, AM Sullivan, Y Nolan.
TITLEFENS Forum of Neuroscience, Vienna, Austria.
PUBLICATION_NAME6-hydroxydopamine-induced p38 activation in rat nigral dopaminergic neurons is reduced by treatment with a novel phospholipid-based drug formulation
YEAR2006
MONTHJanuary
STATUSValidated
PEER_REVIEW1
TIMES_CITED()
SEARCH_KEYWORD
EDITORS
START_PAGE
END_PAGE
LOCATION
START_DATE
END_DATE
ABSTRACT
FUNDED_BY
URL
DOI_LINK
FUNDING_BODY
GRANT_DETAILS